DETEX® BLOX MSDS MANUFACTURER'S ADDRESS: PREPARED BY: TELEPHONE NO: EMERGENCY PHONE NOS: Transportation (Spills) PRODUCT NAME:DETEX® Blox FORMULA: EPA REGISTRATION NO: SECTION I. HAZARDOUS INGREDIENTS INGREDIENT NAME % BY WEIGHT CURRENT TLV This product contains no components subject to the reporting requirements of Section 313 of the Superfund Amendment and Reauthorization Act (SARA) of 1986 SECTION II. PHYSICAL DATA APPEARANCE: SPECIFIC GRAVITY: VAPOR DENSITY: MELTING POINT: WATER REACTIVITY: EVAPORATION RATE: VAPOR PRESSURE: BOILING POINT: SOLUBILITY: BULK DENSITY: SECTION III. FIRE AND EXPLOSION DATA FLASH POINT (Method Used): FLAMMABLE LIMIT: AUTOIGNITION TEMP:
EXTINGUISHING MEDIA: Extinguish with water, foam or inert gas.
SPECIAL FIREFIGHTING PROCEDURES: None
UNUSUAL FIRE OR EXPLOSION HAZARDS: None SECTION IV. REACTIVITY HAZARD DATA STABILITY: CONDITIONS TO AVOID: POLYMERIZATION: CONDITIONS TO AVOID: INCOMPATIBILITY (MATERIALS TO AVOID): HAZARDOUS DECOMPOSITION PRODUCTS: SECTION V. TOXICITY DATA LD50, ORAL (INGESTION): LD50, DERMAL (SKIN CONTACT): LC50, INHALATION: EYE IRRITATION: SKIN IRRITATION: DERMAL SENSITIZATION: DETEX® Blox MSDS SECTION VI. HEALTH HAZARDS PRIMARY ROUTE OF ENTRY: SIGNS & SYMPTOMS OF EXPOSURE:
EMERGENCY FIRST AID PROCEDURES: Eyes: Non-Toxic Skin: Non-Toxic Ingestion: Non-Toxic Inhalation: Non-Toxic NOTE TO PHYSICIAN: N/A SECTION VII. CONTROL AND PROTECTIVE MEASURES
RESPIRATOR TYPE: Not required EYE PROTECTION: GLOVES (Recommended): VENTILATION:
OTHER PROTECTIVE MEASURES: Not required
NATIONAL FIRE PROTECTION ASSOCIATION (NFPA) RATINGS: HEALTH: 0 (Non-Toxic) FIRE: 0 (Will not burn) REACTIVITY: 0 (Stable) SPECIFIC HAZARD: None
HAZARDOUS MATERIALS IDENTIFICATION SYSTEM (HMIS) RATINGS: HEALTH: 0 (Non-Toxic) FLAMMABILITY: 0 (Minimal) REACTIVITY: 0 (Minimal) PROTECTIVE EQUIPMENT: None SECTION VIII. SPILL OR LEAK PROCEDURES
STEPS TO BE TAKEN IN THE EVENT MATERIAL IS RELEASED OR SPILLED: General clean-up
WASTE DISPOSAL METHOD: Wastes resulting from use may be disposed of on-site or at an approved waste disposal facility. Dispose of all wastes in accordance with all Federal, state and local regulations. SECTION IX. SPECIAL PRECAUTIONS AND STORAGE DATA STORAGE TEMPERATURE: AVERAGE SHELF LIFE:
SPECIAL SENSITIVITY (HEAT, LIGHT, MOISTURE): N/A
PRECAUTIONS TO BE TAKEN IN HANDLING AND STORAGE: N/A SECTION X. SHIPPING DATA DOT SHIPPING NAME: DOT HAZARD CLASSIFICATION: DOT LABELS REQUIRED: FREIGHT CLASSIFICATION:
WARRANTY: The information provided in this Material Safety Data Sheet has been obtained from sources believed to be reliable. Bell Laboratories, Inc. provides no warranties, either expressed or implied, and assumes no responsibility for the accuracy or completeness of the data contained herein. This information is offered for your consideration and investigation. The user is responsible to ensure that they have all current data relevant to their particular use.
Wassertabletten, auch bekannt als Diuretika (den Urin befördernd), waren die ersten Medikamente zur Behandlung des Bluthochdrucks. Bis in die heutige Zeit sind entwässernde Mittel nicht aus der Therapie wegzudenken, da sie, mit Sinn und Verstand eingesetzt, eine sehr gute Wirkung zei-gen und die mit Abstand preisgünstigste Therapie darstellen. Wassertabletten — Dr. med. Klaus
REPRINTED WITH PERMISSION FROM THE FIBROMYALGIA NETWORK FDA Approves Second Drug to Treat FibromyalgiaThe U.S. Food and Drug Administration (FDA) approved Cymbalta (duloxetine) on June 16 for treating fibromyalgia. Cymbalta is the first serotonin-norepinephrine reuptake inhibitor (SNRI) that has been proven to reduce pain in fibromyalgia patients. This is the second FDA-approved medication to tr